Kozak & Associates, Inc. Viatris Inc Transaction History

Kozak & Associates, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 05, 2023	SELL	$9.02 - $10.29 $9 - $10	-1 Reduced 2.13%	46 $0
Q1 2023 Apr 03, 2023	BUY	$9.2 - $12.26 $9 - $12	1 Added 2.17%	47 $0
Q2 2022 Oct 12, 2022	SELL	$9.95 - $12.27 $417 - $515	-42 Reduced 47.73%	46 $0
Q4 2021 Mar 11, 2022	BUY	$12.09 - $14.68 $12 - $14	1 Added 1.15%	88 $1,000
Q3 2021 Nov 16, 2021	BUY	$13.25 - $15.13 $1,152 - $1,316	87 New	87 $1,000

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Kozak & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Kozak & Associates, Inc. with notifications on news.